Meloxicam Vaginal Ring
- User: Female
- Hormonal: Non-Hormonal
-
Delivery type:
- Vaginal Ring
-
Intended Duration:
- Short-Acting
- Development Stage: Phase I
- Developer(s)/researcher(s): Laboratorios Andromaco, ICMER
Details
- API: Meloxicam
- Target: COX-2
-
Mechanism of Action:
- Ovulation Inhibition
- Inactive Materials: Polyvinylpyrrolidone K-30
- Regimen: Not Yet Determined
- MPT: Not Potential MPT
- Promising Attributes: Meloxicam has the potential to disrupt ovulation through COX-2 inhibition. Vaginal rings align with growing user desire for user-controlled, reversable, non-invasive methods.
Product Status
Final patent was granted in 2019. There is no credible public information confirming active development after the conclusion of a Phase I trial in 2013.
History
2013: Phase I Trial, NCT01839643
2019: Patent granted on technology